...
首页> 外文期刊>Transplantation Proceedings >Similar Outcomes of Kidney Transplantations Using Organs From Donors After Cardiac Death and Donors After Brain Death
【24h】

Similar Outcomes of Kidney Transplantations Using Organs From Donors After Cardiac Death and Donors After Brain Death

机译:在脑死后心脏死亡和供体后使用施用器官的肾移植的类似蛋白

获取原文
获取原文并翻译 | 示例

摘要

BackgroundTo increase the number of cadaveric kidney transplants in Japan, it is necessary to proactively use organs from all donors. Since the revision of the Organ Transplant Law, the number of organ donors after cardiac death (DCD) has decreased but the number of organ donors after brain death (DBD) has increased; however, the number of donor organs and awareness of cadaveric transplantation have increased. MethodsAt our institution, 28 patients underwent cadaveric kidney transplantation from January 2001 to December 2016. These patients were classified into 2 groups according to DBD or DCD. Furthermore, 10 patients received transplants from expanded criteria donors (ECD) and 18 received them from standard criteria donors (SCD). ResultsKidney graft survival and engraftment were observed for all patients. There were no significant differences in renal function at 6 months for DBD and DCD transplant recipients. Renal function at 1, 3, and 5 years and serum creatinine levels were better for the ECD group. Renal function at 5 years after transplantation was significantly better for the SCD group than for the ECD group; however, there was no difference in delayed graft function between the SCD and ECD groups. Comparisons of the 3 groups showed good renal function for transplants from DBDs, but there was no significant difference in survival rates. ConclusionsResults were good for all patients. There were no significant differences in outcomes of our patients who received transplants from ECD or SCD.
机译:背景技术增加日本的尸体肾脏移植数量,有必要积极地使用来自所有捐赠者的器官。由于器官移植法的修订,心脏死亡后器官供体的数量(DCD)减少,但脑死亡后的器官供体数量增加(DBD)增加;然而,供体器官的数量和尸体移植的意识增加了。 MethaSTIMAT,28名患者从2001年1月到2016年1月到12月接受了尸体肾移植的患者。根据DBD或DCD,将这些患者分为2组。此外,10名患者接受来自扩展标准供体(ECD)的移植和18名从标准标准供体(SCD)中获得。所有患者都观察到结果kidney嫁接生存和植入。对于DBD和DCD移植接受者,6个月肾功能差异无显着差异。肾功能在1,3和5年,血清肌酐水平对ECD组更好。对SCD组的移植5年后5年的肾功能比ECD集团明显更好;但是,SCD和ECD组之间的延迟移植函数没有差异。 3组的比较显示了达克斯的移植移植的良好肾功能,但存活率没有显着差异。结论事项对所有患者都有益。我们从ECD或SCD移植的患者的结果没有显着差异。

著录项

  • 来源
    《Transplantation Proceedings 》 |2018年第8期| 共8页
  • 作者单位

    Department of Kidney Transplantation Surgery Tokyo Medical University Hachioji Medical Center;

    Department of Kidney Transplantation Surgery Tokyo Medical University Hachioji Medical Center;

    Department of Kidney Transplantation Surgery Tokyo Medical University Hachioji Medical Center;

    Department of Kidney Transplantation Surgery Tokyo Medical University Hachioji Medical Center;

    Department of Kidney Transplantation Surgery Tokyo Medical University Hachioji Medical Center;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 器官移植术 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号